Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,815 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704).
Sato Y, Kurokawa Y, Doki Y, Mizusawa J, Tanaka K, Katayama H, Boku N, Yoshikawa T, Terashima M; Stomach Cancer Study Group/Japan Clinical Oncology Group. Sato Y, et al. Among authors: tanaka k. Future Oncol. 2020 Feb;16(4):31-38. doi: 10.2217/fon-2019-0528. Epub 2020 Jan 10. Future Oncol. 2020. PMID: 31920105 Clinical Trial.
A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311).
Ishikawa M, Nakamura K, Shibata T, Tanaka K, Kitagawa R, Kobayashi H, Yaegashi N; Gynecologic Cancer Study Group of the Japan Clinical Oncology Group. Ishikawa M, et al. Among authors: tanaka k. Jpn J Clin Oncol. 2018 Dec 1;48(12):1096-1100. doi: 10.1093/jjco/hyy137. Jpn J Clin Oncol. 2018. PMID: 30295796 Clinical Trial.
Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND).
Tanaka K, Hanai N, Eba J, Mizusawa J, Asakage T, Homma A, Kiyota N, Fukuda H, Hayashi R; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group. Tanaka K, et al. Jpn J Clin Oncol. 2018 Dec 1;48(12):1105-1108. doi: 10.1093/jjco/hyy125. Jpn J Clin Oncol. 2018. PMID: 30346569 Clinical Trial.
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A.
Tanaka K, Ogawa G, Mizusawa J, Kadota T, Nakamura K, Shimada Y, Hamaguchi T, Fujita S, Kitano S, Inomata M, Kanemitsu Y, Fukuda H; Colorectal Cancer Study Group of Japan Clinical Oncology Group (JCOG). Tanaka K, et al. Jpn J Clin Oncol. 2021 Feb 8;51(2):185-191. doi: 10.1093/jjco/hyaa184. Jpn J Clin Oncol. 2021. PMID: 33157551
A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).
Shimomura A, Tamura K, Tanaka K, Mizutani T, Sasaki K, Sekino Y, Sawaki M, Shien T, Shibata T, Iwata H. Shimomura A, et al. Among authors: tanaka k. Jpn J Clin Oncol. 2021 Aug 30;51(9):1471-1474. doi: 10.1093/jjco/hyab101. Jpn J Clin Oncol. 2021. PMID: 34215870 Clinical Trial.
Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: an ancillary study of JCOG0306.
Shien T, Tsuda H, Sasaki K, Mizusawa J, Akiyama F, Kurosumi M, Sawaki M, Tamura N, Tanaka K, Kogawa T, Takahashi M, Hayashi N, Mukai H, Masuda N, Hara F, Iwata H. Shien T, et al. Among authors: tanaka k. Breast Cancer Res Treat. 2024 Nov;208(1):145-154. doi: 10.1007/s10549-024-07408-5. Epub 2024 Jun 27. Breast Cancer Res Treat. 2024. PMID: 38935214 Free PMC article. Clinical Trial.
Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE).
Tanaka K, Tsutani Y, Wakabayashi M, Mizutani T, Aokage K, Miyata Y, Kuroda H, Saji H, Watanabe SI, Okada M; behalf of the Lung Cancer Surgical Study Group/Japan Clinical Oncology Group. Tanaka K, et al. Jpn J Clin Oncol. 2020 Sep 5;50(9):1076-1079. doi: 10.1093/jjco/hyaa092. Jpn J Clin Oncol. 2020. PMID: 32548619 Clinical Trial.
Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol).
Tanaka K, Nakamura Y, Mizutani T, Shibata T, Tsutsumida A, Fukuda H, Matsushita S, Aoki M, Namikawa K, Ohe S, Fukushima S, Yamazaki N; Dermatologic Oncology Group of the Japan Clinical Oncology Group. Tanaka K, et al. BMC Cancer. 2019 Oct 25;19(1):1002. doi: 10.1186/s12885-019-6248-2. BMC Cancer. 2019. PMID: 31653251 Free PMC article. Clinical Trial.
Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).
Shimomura A, Tamura K, Tanaka K, Mizutani T, Sasaki K, Sekino Y, Sawaki M, Shien T, Shibata T, Iwata H. Shimomura A, et al. Among authors: tanaka k. Jpn J Clin Oncol. 2021 Aug 30;51(9):1479. doi: 10.1093/jjco/hyab124. Jpn J Clin Oncol. 2021. PMID: 34296283 No abstract available.
18,815 results
You have reached the last available page of results. Please see the User Guide for more information.